FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
More than half say they would give up takeout, dining out, or streaming services to afford non-surgical procedures, according to new consumer data.